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Abstract 
In this paper, we report the optimal conditions for the isolation of amino acid arginine from different types 
of matrix, such as blood, plasma or tissue and their characterization using ion-exchange liquid chromatography 
with VIS detector. Paramagnetic microparticles able to isolate and immobilize amino acid arginine were 
prepared and used to preconcentrate arginine for subsequent analysis on ion-exchange liquid chromatography 
with VIS detector. Commercially available Dowex was covered by maghemite nanoparticles and the composite 
showed excellent binding and superparamagnetic properties. It was found that the paramagnetic 
microparticles were able to bind specifically amino acid arginine. Therefore, these paramagnetic microparticles 
have potential for better isolation of arginine and in future can use for application as a platform of delivery 
system. 
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1. INTRODUCTION 
Arginine is semiessential amino acid and plays a various roles in biosynthetic pathways in tumor biology [1]. 
Major cellular functions of arginine were nitric oxide production [2], creatine production and polyamine 
synthesis [3]. Arginine influences in tumor cells has been shown to inhibit metastatic tumor growth [4]. Long-
term and significant of arginine deprivation induces free radical formation and peroxynitrite stress especially in 
connection to arginine-dependent cancer cells [5]. Based on intensive study, it was shown the effect of arginine 
is to reduce nitric oxide (NO) production and the significant increase of oxidative stress [6]. On the other hand, 
L-arginine regulates blood flow, is the main cause of blood pressure and increased of the oxidative stress 
conditions of patients suffering from cardiomyopathy [7]. L-arginine, shows various functions in human health 
and may play a major role in age-related degenerative diseases such as Alzheimer's disease (AD) [8]. 
Nowadays, multiple methods are developed for semiessential amino acid arginine determination. Most of them 
are based on chromatography (GC, LC, UHPLC) [9] with tandem of mass spectrometry (MS) [10], IEC [11] or 
CE [12]. In our study we decided to use ion exchange chromatography with post-column ninhydrin 
derivatization and VIS detector for arginine determination [13]. 
2. METHODOLOGICAL BASES AND EXPERIMENTAL PART 
2.1. Chemicals 
Arginine of purity 99 % was obtained from Sigma Aldrich (St. Louis, Missouri, USA).  Solution of arginine for 
preparing of calibration curve was prepared in the dilution buffer Na: TDG (NaN3 - 0.10 g, NaCl -11.5g, C6H8O7-
14 per 1L H2O). For experiment were used Citric acid, NaCl, NaN3, TDG, HCl 35 % from Sigma - Aldrich, 
Ninhydrine from Sigma - Aldrich, Methylcellosolve (Ingos, Prague, Czech Republic), SnCl2 (Ingos). 




2.2. Ionex chromatography  
An AAA 400 (Ingos, Czech Republic) liquid chromatography apparatus was used for determination of amino 
acids. The system consists of a glassy filling chromatographic column and steel precolumn, two 
chromatographic pumps for transport of elution buffers and derivatization reagent, cooled carousel for 25 test 
tubes of 1.5-2.0 mL volume, dosing valve, heat reactor, VIS detector and cooled chamber for derivatization 
reagent. Chromatographic columns for transfer of elution buffers and derivatization reagent are able to work 
at flow 0.01-10 mL•min−1 under a maximum pressure of 40 MPa. Volume of injected sample was 100 µL with 
an accuracy of application RSD of about 1 %. A two-channel VIS detector with a 5 µL flow volume cuvette was 
operated at wavelengths of 440 and 570 nm. 
2.3. SECM characterization of DOWEX modified maghemite particles  
Structure and elemental composition of paramagnetic microparticles were characterised by electron 
microscope. For documentation of the selected nanomaterials a FEG-SEM MIRA XMU (Tescan, a.s., Brno, 
Czech Republic) was used. This model is equipped with a high brightness Schottky field emitter for low noise 
imaging at fast scanning rates. The SEM was fitted with Everhart-Thronley type of SE detector, high speed 
YAG scintillator based BSE detector, panchromatic CL Detector and EDX spectrometer. The MIRA 3 XMU 
system is based on a large specimen chamber with motorized stage movements 130×130 mm. Samples were 
coated by 10 nm of carbon to prevent sample charging. A carbon coater K950X (Quorum Technologies, 
Grinstead, United Kingdom) was used. For automated acquisition of selected areas a TESCAN proprietary 
software tool called Image Snapper was used. The Accepted Article software enables automatic acquisition 
of selected areas with defined resolution. Different conditions were optimized in order to reach either minimum 
analysis time or maximum detail during overnight automated analysis. An accelerating voltage of 15 kV and 
beam currents about 1 nA gives satisfactory results regarding maximum throughput. 
2.4. X-ray fluorescence analysis of PMPs 
XRF elemental analysis of PMPs was carried out on Xepos (SPECTRO analytical instruments GmbH, Kleve, 
Germany) fitted with three detectors: Barkla scatter - aluminium oxide, Barkla scatter - HOPG and 
Compton/secondary molybdenum respectively. Analyses were conducted in Turbo Quant cuvette method 
of measuring. Analysis parameters were set to - measurement duration: 300 seconds, tube voltage from 24.81 
to 47.72 kV, tube current from 0.55 to 1.0 mA, with zero peak at 5000 cps and vacuum switched off. 
2.5. Preparation of microparticles   
Maghemite nanoparticles were prepared by sodium borohydride (NaBH4) reduction of iron chloride 
(FeCl3.6H2O). The product was separated by a magnet, washed with water and dried at 40 °C. Product was 
heated at 400 ºC for approximately 1 h in the muffle furnace (Verkon, Prague, Czech Republic). Product has 
a red color and was dispersed in water. To this solution was added Dowex with stirring on Biosan OS-10 
overnight. Then the product was separated by a magnet, washed with water and dried at 40 °C. 
3. RESULTS AND DISCUSSION 
Aim of our study was an mainly isolation and 2D separation of the semiessential amino acid arginine, able to 
serve as a possible marker of metastatic tumor growth inhibition, based on the adsorption on the paramagnetic 
microparticles on commercially available Dowex and subsequent determination using ion-exchange liquid 
chromatography (IEC). We modified Dowex with nanomaghemite and NH2 functional groups, and these PMPs 
showed excellent properties for binding of arginine (recovery 42.48 %) (Figure 1.A). Britton-Robinson buffer 
with pH 2 causes semiessential amino acid arginine protonation which leads to a positive charging 
of molecules due to its pI = 10.76. Interaction between surface of our magnetic microparticles and positively 
charged molecule provides the binding between them. These interactions depend on isoelectric point of amino 




acid, which are in this mode behaving as the ion-exchangers. Other amino acids and tripeptides such as GSH 
and GSSG, showed also relatively good recoveries (serine recovery 1.1 %, leucine 10 %, sarcosine 1.3 %, 
GSSG 0.5 %,GSH 0.45 %, glutamic acid 6.7 %, glycine 0.8 %, valine 4.35 % and arginine 42.48 %, 
respectively); however, their quantity in real sample of blood are not so high to interfere during arginine binding 
to PMPs (Figure 1D). Furthermore, our second separation step - analysis using Ion Exchange 
Chromatography (IEC) - eliminates the influence of interferents to a minimum. 
 
Figure 1 Characterization of PMPs. (A) XRF showing elemental composition of paramagnetic microparticles. 
(B) SEM image in resolution of 20 µm. (C) SEM scan in resolution of 500 nm. (D) IEC results showing ability 
of PMPs bound required substances specifically. (E) SECM scan showing relative current response of PMPs 
without arginine bound. (F) SECM scan of PMPs with arginine bound showing increased relative current 
response.  
After confirmation of capability to bind amino acid arginine, we carried out a various characterization of PMPs. 
Primarily characterization was XRF analysis providing information about elemental composition 
of microparticles. In the Figure 1A can be seen that iron was determined to be the most abundant element 
(Fe represented in 54.56 %) and cobalt (Co represented 0.1772 %). This information was not surprising, 
because we carried out SECM analysis for recognition of PMPs surface relative current response changes in 
dependence on arginine binding. In Fig 1B can be seen a micrograph expressing microparticles surface and 
morphology in resolution of 20 µm for PMPs and in Figure 1C is SEM micrograph of PMP surface in resolution 
of 500 nm. In Figure 1E, F can be seen 3D images, expressing a relative current response of PMP surface 
without arginine and with arginine bound. 





In this study, we synthesized paramagnetic microparticles able to bind semiessential amino acid arginine - as 
a possible marker of metastatic tumor growth inhibition. The paramagnetic microparticles have potential to 
better isolation of arginine from the samples of plasma, cells or tissue and in future can serve for application 
as a platform for delivery system.  
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